BREAKING
Home » Archive by Category "Drugs and antibiotics"

RSV drug, Beyfortus, gets FDA nod for protecting newborns and infants

By

NewsDesk @bactiman63 The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus™ (nirsevimab-alip) for the prevention of respiratory syncytial virus (RSV) lower respiratory...

FDA approves antibiotic, Xacduro, for the treatment of pneumonia caused by Acinetobacter baumannii

By

NewsDesk @bactiman63 Last week, the U.S. Food and Drug Administration approved Xacduro (sulbactam for injection; durlobactam for injection), a new treatment for hospital-acquired bacterial pneumonia...

FDA Approves Oral Antiviral Paxlovid for Treatment of COVID-19 in Adults

By

NewsDesk @bactiman63 Last week, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate...

Sanofi’s Nirsevimab shows 83% reduction in RSV infant hospitalizations, according to data

By

NewsDesk @bactiman63 Nirsevimab is a long-acting antibody designed for all infants for protection against RSV disease from birth through their first RSV season with a single dose, is being developed jointly...

Mpox drug, tecovirimat, outcomes are similar regardless of HIV status

By

NewsDesk @bactiman63 Mpox patients treated with tecovirimat, an antiviral drug widely used since last summer’s outbreak, had similar outcomes regardless of HIV status, researchers at Columbia University’s...

REZZAYO approved by FDA amid rapid Candida auris spread

By

NewsDesk @bactiman63 On Monday, the CDC reported an increasing threat of the emerging fungus Candida auris. Today, the U.S. FDA today approved Cidara Therapeutics and Melinta Therapeutics’ REZZAYOTM...

Novel combination therapy developed for treating VRE

By

NewsDesk @bactiman63 Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise...

Novel Candidate Tuberculosis Treatment Compound Licensing Agreement Between Calibr and Bill & Melinda Gates Medical Research Institute

By

Calibr, a division of Scripps Research dedicated to the “bench to bedside” development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute (Gates MRI), today announced...

FDA Approves First-In-Class HIV Treatment Option

By

Gilead Sciences, Inc. announced this week that Sunlenca® (lenacapavir), in combination with other antiretroviral(s) (ARV), has been granted approval by the U.S. Food and Drug Administration (FDA) for the...

FDA Approves Actemra for the Treatment of COVID-19 in Hospitalized Adults

By

NewsDesk @bactiman63 Genentech today announced that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult...